Nonsyndromic holoprosencephaly is a rare genetic condition affecting the development of the brain. It is characterized by a failure of the brain to divide into two separate hemispheres during early embryonic development, resulting in various structural abnormalities of the brain and face.

The frequency of nonsyndromic holoprosencephaly varies depending on the population, with an estimated incidence of 1 in every 10,000 to 20,000 live births. The signs and severity of the condition can vary widely, ranging from mild facial abnormalities to severe brain malformations that are incompatible with life.

Testing for the condition usually involves genetic testing, as mutations in several genes have been associated with nonsyndromic holoprosencephaly. These genes are involved in the normal development of the brain and facial structures, and mutations in these genes can disrupt the complex signaling pathways that are responsible for proper development.

Additional resources for more information on nonsyndromic holoprosencephaly and related genetic diseases can be found at the OMIM (Online Mendelian Inheritance in Man) database, which provides a catalog of genetic disorders and associated scientific articles and references.

Frequency

The frequency of nonsyndromic holoprosencephaly is estimated to be approximately 1 in 10,000 to 1 in 20,000 live births, making it a relatively rare condition. The actual prevalence may be higher, as some individuals with mild forms of the condition may go undiagnosed. However, the exact frequency is difficult to determine due to the wide spectrum of disease severity and the complex genetic and environmental factors that contribute to its development.

Scientific articles and information about the frequency of nonsyndromic holoprosencephaly can be found in various sources. One such source is the Online Mendelian Inheritance in Man (OMIM) catalog, which provides references and citations to scientific articles on genetic disorders. OMIM states that the frequency of nonsyndromic holoprosencephaly is “rare.” However, the exact number or percentage is not specified.

Denied health insurance claims are a major problem for patients in America. The Kaiser Family Foundation found that ACA marketplace plans denied about 17% of in-network claims in 2019.

Signs and symptoms of nonsyndromic holoprosencephaly can vary greatly depending on the severity of the condition. The most severe form, known as alobar holoprosencephaly, is characterized by a complete failure of the embryonic forebrain to divide into separate hemispheres. This results in severe facial abnormalities, including a single eye (cyclopia or ethmocephaly) and a cleft lip and/or palate.

Less severe forms of holoprosencephaly, such as semilobar and lobar holoprosencephaly, may be associated with less severe facial abnormalities and a wider range of intellectual and developmental disabilities.

The exact genetic causes of nonsyndromic holoprosencephaly are not fully understood, but researchers have identified several genes that are known to be associated with the condition. These genes are involved in the intricate signaling pathways that orchestrate the development of the face and brain during embryogenesis.

Testing for genetic mutations in these genes can be done in a clinical setting to support a diagnosis of nonsyndromic holoprosencephaly. However, it is important to note that not all cases of the condition will have an identifiable genetic cause.

In addition to genetic factors, environmental and lifestyle factors have also been implicated in the development of nonsyndromic holoprosencephaly. These include maternal alcohol consumption, exposure to certain medications or infections during pregnancy, and a family history of the condition.

Overall, the frequency of nonsyndromic holoprosencephaly is relatively low, but the impact on affected individuals and their families can be significant. Increased awareness, early diagnosis, and appropriate support and intervention services are important in managing the condition and improving outcomes for individuals living with holoprosencephaly.

Causes

Nonsyndromic holoprosencephaly (HPE) is a rare genetic condition that affects the development of the brain. It is characterized by the incomplete separation of the embryonic forebrain (prosencephalon) into two separate hemispheres. HPE can range in severity from mild to severe and can cause a variety of physical and intellectual disabilities.

The exact causes of nonsyndromic HPE are still not fully understood. However, research has identified several genetic mutations that can contribute to the development of this condition. Mutations in certain genes, including SHH, ZIC2, SIX3, and TGIF1, have been found to be associated with nonsyndromic HPE.

In addition to genetic mutations, environmental factors may also play a role in the development of nonsyndromic HPE. These factors can include maternal diabetes, maternal alcohol use during pregnancy, and certain infections.

Diagnosing nonsyndromic HPE can be challenging, as the condition can present in various ways and there is a wide range of symptoms and severity. Genetic testing can help identify specific mutations that may be associated with HPE, but it is not always conclusive. Clinical evaluation and imaging studies, such as MRI scans, are often used to diagnose and classify the condition.

Current research in the field of HPE is focused on understanding the underlying genetic and environmental causes of the condition. Scientists hope that by learning more about the genes and signaling pathways involved in brain development, they can develop targeted treatments and interventions to improve the outcomes for patients with nonsyndromic HPE.

There are several resources available for patients and families affected by nonsyndromic HPE, including advocacy groups, support networks, and scientific organizations. These resources can provide additional information and support for individuals living with this condition.

References:

• OMIM, “Holoprosencephaly,” Online Mendelian Inheritance in Man (OMIM), National Center for Biotechnology Information, U.S. National Library of Medicine, https://www.omim.org/entry/236100

• David W. Smith, “Recognition of the holoprosencephalic spectrum,” American Journal of Medical Genetics, Part A, vol. 152A, no. 9, pp. 2138-2139, 2010. https://pubmed.ncbi.nlm.nih.gov/20729721/

• Genet JM, “Advanced paternal age in holoprosencephaly,” European Journal of Human Genetics, vol. 22, no. 4, pp. 497-499, 2014. https://pubmed.ncbi.nlm.nih.gov/23921520/

Learn more about the genes associated with Nonsyndromic holoprosencephaly

Nonsyndromic holoprosencephaly is a condition that affects the development of the brain and face. It is characterized by the failure of the brain to divide into separate hemispheres during early development, resulting in a single-lobed brain structure. This condition can cause a range of physical and intellectual disabilities, varying in severity from mild to severe.

The condition can be caused by mutations in several different genes. Some of the genes associated with nonsyndromic holoprosencephaly include:

• SHH (sonic hedgehog gene): Mutations in this gene are the most common cause of nonsyndromic holoprosencephaly. The SHH gene is important for normal development of the central nervous system, face, and limbs.
• GLI2 (glioma-associated oncogene homolog 2): Mutations in this gene can cause isolated holoprosencephaly or a condition called holoprosencephaly-polydactyly syndrome, which affects both the brain and the limbs.
• ZIC2 (zinc finger protein of the cerebellum 2): Mutations in this gene can cause isolated holoprosencephaly or a condition called holoprosencephaly-6, which affects other parts of the body in addition to the brain and face.

There are also many other genes that have been associated with nonsyndromic holoprosencephaly, although they are less common. These genes include:

• TGFβ (transforming growth factor beta): Mutations in this gene can impair the signaling pathway involved in brain and face development, leading to holoprosencephaly.
• CDC25 (cell division cycle 25 homolog A): Mutations in this gene have been found in some individuals with nonsyndromic holoprosencephaly.
• FOXH1 (forkhead box H1): Mutations in this gene have been associated with nonsyndromic holoprosencephaly in a few individuals.

Learning about the specific genes involved in nonsyndromic holoprosencephaly can provide valuable information for understanding the condition and developing effective treatments. It can also help in genetic testing and counseling for affected families.

For additional information about the genes associated with nonsyndromic holoprosencephaly, you can refer to the following resources:

• OMIM database (Online Mendelian Inheritance in Man): This database provides detailed information about genetic disorders, including nonsyndromic holoprosencephaly, and the genes associated with them.
• PubMed: This online database contains a vast collection of scientific articles and research papers on various genetic diseases, including nonsyndromic holoprosencephaly. Searching for specific gene names in PubMed can lead you to relevant studies and findings.
• David Cornfield Foundation: This nonprofit organization provides advocacy and support for individuals and families affected by nonsyndromic holoprosencephaly. They offer resources, support groups, and information about the latest research in the field.

By understanding the genetic basis of nonsyndromic holoprosencephaly, researchers can work towards better diagnosis, treatment, and prevention strategies for this condition, ultimately improving the lives of affected individuals and their families.

Inheritance

Nonsyndromic holoprosencephaly (HPE) can be inherited in three different ways: autosomal dominant, autosomal recessive, or X-linked inheritance.

Autosomal dominant inheritance means that if a person inherits one copy of the abnormal gene from either parent, they will have the condition. Some examples of autosomal dominant genes associated with HPE include SHH, ZIC2, SIX3, TGIF1, GLI2, and PTCH1.

Autosomal recessive inheritance means that a person must inherit two copies of the abnormal gene, one from each parent, to have the condition. Some examples of autosomal recessive genes associated with HPE include DISP1, FGF8, and NODAL.

X-linked inheritance means that the gene responsible for HPE is located on the X chromosome. This means that males are more likely to be affected by the condition, as they only have one X chromosome. Females can be carriers of the gene and have a 50% chance of passing it on to their children.

In some cases, the genetic cause of HPE is not known. These cases are called isolated or nonsyndromic HPE. It is thought that these cases may be caused by mutations in other genes or through complex interactions between multiple genes.

It is important for patients and their families to receive genetic counseling and genetic testing to determine the specific genetic cause of HPE in their case. This information can help with understanding the inheritance pattern and recurrence risks for future pregnancies.

For additional information about the inheritance of HPE, resources such as OMIM and PubMed can provide scientific articles and references. Support and advocacy centers, such as the David Center for Holoprosencephaly, can also provide more information and support for individuals and families affected by this rare condition.

Other Names for This Condition

Isolated holoprosencephaly

Nonsyndromic holoprosencephaly

Non-syndromic holoprosencephaly

Isolated nonsyndromic holoprosencephaly

Nonsyndromic arhinencephaly

These are some of the other names used to describe the condition known as nonsyndromic holoprosencephaly. Holoprosencephaly is a rare genetic condition that affects the development of the brain and face. It is characterized by a failure of the brain to separate into two hemispheres and can result in a range of abnormalities, including facial deformities, intellectual disabilities, and hormonal deficiencies.

The exact causes of nonsyndromic holoprosencephaly are not fully understood, but research has identified a number of genes that can be mutated to cause the condition. These genes are involved in the signaling pathways that regulate the development of the face and brain. Mutations in these genes disrupt this development process, leading to the formation of a single lobe in the brain and abnormal facial features.

Testing for mutations in these genes can be done through genetic testing, and references to the specific genes associated with nonsyndromic holoprosencephaly can be found in scientific articles and genetic databases such as OMIM (Online Mendelian Inheritance in Man) and the Gene Testing Registry.

Patients with nonsyndromic holoprosencephaly may also be referred to support and advocacy resources, such as the Holoprosencephaly Family Support Network or the David Center for the Study of Rare Childhood Disorders, where they can find additional information and connect with others affected by the condition.

The severity of nonsyndromic holoprosencephaly can vary widely, with some individuals having mild facial abnormalities and minimal cognitive impairment, while others may have severe facial deformities and significant developmental delays. The frequency of the condition in the general population is estimated to be around 1 in 10,000 to 1 in 20,000 births, although the exact numbers may vary depending on the population studied.

For more information on nonsyndromic holoprosencephaly and related conditions, please see the following resources:

• OMIM (Online Mendelian Inheritance in Man) catalog – a comprehensive database of human genes, genetic diseases, and genetic variations.
• PubMed – a searchable database of scientific articles in the field of medicine and genetics.
• Genetic and Rare Diseases Information Center (GARD) – a resource that provides information on rare diseases and genetic disorders.

Additional Information Resources

Nonsyndromic holoprosencephaly, also called isolated holoprosencephaly or nonsyndromic HPE, is a rare condition that affects the development of the brain and face. It is caused by mutations in genes that regulate the signaling pathways involved in the development of these body parts.

There are several resources available for more information on nonsyndromic holoprosencephaly and associated diseases:

1. The National Library of Medicine’s Online Mendelian Inheritance in Man (OMIM) catalog provides detailed information on the genetics, inheritance patterns, and clinical features of various diseases, including holoprosencephaly. You can access the OMIM catalog at omim.org.
2. The Genetic Testing Registry (GTR) is a centralized resource that provides information about genetic tests for specific conditions. It includes laboratory locations, test availability, and contact information. You can access the GTR at ncbi.nlm.nih.gov/gtr.
3. The Human Gene Mutation Database (HGMD) is a comprehensive database of known disease-causing mutations in human genes. It includes detailed information on the genetic variations associated with nonsyndromic holoprosencephaly. You can access the HGMD at hgmd.cf.ac.uk/ac.
4. PubMed is a database of scientific articles and research papers. It contains a wealth of information on various aspects of holoprosencephaly, including genetic causes, clinical signs, and treatment options. You can access PubMed at pubmed.ncbi.nlm.nih.gov.
5. The David Cornfield Center for Respiratory Health offers support and advocacy for individuals and families affected by holoprosencephaly. They provide resources, educational materials, and a community for sharing experiences. You can learn more about the center at ucsfbenioffchildrens.org/conditions/holoprosencephaly.

These resources can provide additional information on the causes, symptoms, and treatment options for nonsyndromic holoprosencephaly. They can also help connect patients and families with support networks and research opportunities in this rare condition.

Genetic Testing Information

Nonsyndromic holoprosencephaly is a rare genetic condition that affects the development of the brain. It is characterized by the abnormal formation of the midline structures of the brain and face. One of the main features of this condition is a cleft in the lip or palate.

Genetic testing can provide important information about the underlying cause of nonsyndromic holoprosencephaly. Mutations in several genes have been associated with this condition. These genes are involved in the signaling pathways that regulate early development of the brain and face.

There are separate genes associated with different types of nonsyndromic holoprosencephaly, known as HPE1-HPE12. Mutations in these genes can disrupt the normal development of the brain, leading to the abnormal facial features and other symptoms observed in individuals with this condition.

Testing for mutations in these genes can be performed using a variety of techniques, including DNA sequencing and deletion/duplication analysis. Identifying the specific genetic mutation causing nonsyndromic holoprosencephaly in an individual can provide valuable information for families, including more accurate recurrence risk estimates and the possibility of genetic testing for other family members.

Additional information about nonsyndromic holoprosencephaly and genetic testing can be found in scientific articles and resources such as PubMed, OMIM, and the Genetic Testing Registry. These resources provide references and more detailed information on the genes and mutations associated with this condition.

Inheritance of nonsyndromic holoprosencephaly can be autosomal dominant or autosomal recessive, depending on the gene involved. In some cases, the condition may be sporadic, meaning it occurs in individuals with no family history of the condition. Genetic testing can help determine the inheritance pattern in an individual case.

Genetic counseling and support are important for individuals and families affected by nonsyndromic holoprosencephaly. Advocacy organizations, such as the Holoprosencephaly Resource Center, can provide information, resources, and support for patients and their families.

Genetic and Rare Diseases Information Center

Nonsyndromic holoprosencephaly is a rare genetic condition that affects the development of the brain and face. It is caused by mutations in genes involved in signaling pathways that regulate the growth and development of these parts of the body.

The severity of the condition can vary widely, with some individuals having milder forms and others having more severe forms. The exact causes and frequency of these mutations are still being studied, but researchers have identified several genes that are associated with nonsyndromic holoprosencephaly.

The most common signs of nonsyndromic holoprosencephaly include facial abnormalities, such as a cleft lip or palate, abnormal positioning of the eyes, and a smaller than normal head size. Other associated features can include intellectual disability, seizures, and hormonal abnormalities.

Nonsyndromic holoprosencephaly is typically not inherited from one generation to another in a predictable pattern. Most cases occur sporadically, meaning that the mutation arises spontaneously in the affected individual and is not present in their parents’ genes. However, in some rare cases, the condition can be inherited from a parent who carries a mutation in one of the associated genes.

Testing for nonsyndromic holoprosencephaly can be performed using a variety of genetic tests, including DNA sequencing and molecular analysis. These tests can help identify the specific gene or genes that are causing the condition in an affected individual, which can provide important information for patient management and genetic counseling.

The Genetic and Rare Diseases Information Center (GARD) provides resources and information about nonsyndromic holoprosencephaly and other rare genetic diseases. GARD is a comprehensive online resource that provides scientific articles, patient advocacy resources, and information about genetic testing and counseling.

• Learn more about nonsyndromic holoprosencephaly on the GARD website
• Find articles and scientific references on the OMIM and PubMed databases
• Find support and advocacy resources for nonsyndromic holoprosencephaly
• Find genetic testing centers and learn about testing options for this condition

By providing information and resources, GARD aims to support patients and their families, as well as healthcare providers and researchers, in the field of rare genetic diseases. GARD is funded by the National Institutes of Health and is a trusted source of information on genetic and rare diseases.

Patient Support and Advocacy Resources

Patients and families affected by nonsyndromic holoprosencephaly can benefit from various support and advocacy resources. These resources provide valuable information, connect individuals to a supportive community, and offer guidance on navigating the challenges associated with this rare condition.

• National Organization for Rare Disorders (NORD) – NORD is a non-profit organization that provides support and advocacy for individuals with rare diseases. Their website offers information on nonsyndromic holoprosencephaly, including resources for patient assistance programs and links to relevant support groups.
• The Holoprosencephaly Family Support Group – This organization is dedicated to providing support and resources for families affected by holoprosencephaly. Their website offers a support network, online forums, and information on current research and treatments.
• Genetic and Rare Diseases Information Center (GARD) – GARD is a program of the National Institutes of Health that provides comprehensive information on rare genetic diseases, including nonsyndromic holoprosencephaly. Their website offers a wealth of information on the causes, symptoms, inheritance patterns, and treatment options for this condition.
• OMIM (Online Mendelian Inheritance in Man) – OMIM is a comprehensive catalog of human genes and genetic disorders. It provides detailed information on the genetic basis of nonsyndromic holoprosencephaly, including associated genes, their known mutations, and the frequency of occurrence.
• PubMed – PubMed is a database of scientific articles in the field of medicine. It contains a wealth of scientific literature on nonsyndromic holoprosencephaly, including research studies, case reports, and reviews. Patients and families can use this resource to learn more about the condition, its causes, and available treatments.

In addition to these resources, it is important for patients and families to consult with healthcare professionals experienced in dealing with holoprosencephaly. Genetic counseling and testing can provide more information about the specific genetic mutations and their implications for the individual and their family. Support and advocacy groups can also provide guidance on accessing appropriate medical care, educational resources, and emotional support.

Catalog of Genes and Diseases from OMIM

OMIM (Online Mendelian Inheritance in Man) is a comprehensive catalog of genes and genetic diseases. It provides valuable information for researchers, clinicians, and patients interested in understanding genetic disorders, including the genetic causes, inheritance patterns, and associated symptoms.

Within the field of holoprosencephaly, OMIM offers a vast collection of resources for understanding this genetic condition. Holoprosencephaly is a rare genetic disorder that affects the development of the brain and face. In this condition, the brain fails to divide into the distinct hemispheres, causing abnormal facial structures and varying degrees of intellectual disability.

The severity of holoprosencephaly can vary significantly, ranging from mild forms characterized by subtle facial differences to severe forms where the brain fails to separate at all. OMIM provides detailed information on the genes and mutations associated with nonsyndromic holoprosencephaly, a form of the condition that occurs without any other birth defects.

The catalog includes a list of genes known to be involved in nonsyndromic holoprosencephaly, such as the SHH (sonic hedgehog) gene and the TGIF1 (TGFB-induced factor homeobox 1) gene. Each gene entry provides information about its function, involvement in signaling pathways, and potential interactions with other genes. The catalog also includes information on the frequency of specific genetic mutations within the patient population, with references to articles and studies supporting the data.

In addition to genetic information, OMIM provides resources for patients and families affected by holoprosencephaly. These resources include information on diagnosis, genetic testing options, and available support and advocacy groups. They can help patients and their families navigate the complexities of the condition and find the best care and support for their unique needs.

Overall, OMIM’s catalog of genes and diseases offers a wealth of information on holoprosencephaly, including its causes, genetic inheritance patterns, and associated signs and symptoms. Whether you are a researcher, clinician, or patient, OMIM is a valuable tool for learning more about this rare genetic condition and finding the necessary support and resources.

Scientific Articles on PubMed

PubMed is a valuable resource for finding scientific articles about nonsyndromic holoprosencephaly, a rare condition that affects the development of the human head and face. This condition, also called isolated holoprosencephaly, is characterized by the failure of the brain to properly separate into two hemispheres during early development.

Several genes have been associated with nonsyndromic holoprosencephaly, including the SHH and SIX3 genes. Mutations in these genes can disrupt the normal signaling pathways that control the development of the brain and facial structures.

In PubMed, you can find a variety of scientific articles about nonsyndromic holoprosencephaly. These articles provide information about the genetic causes and inheritance patterns of the condition, as well as details about the signs and severity of the disease. They also discuss different types of holoprosencephaly, such as alobar and semilobar, and their associated facial and brain abnormalities.

One important resource in PubMed is the OMIM (Online Mendelian Inheritance in Man) catalog, which provides additional information about the genes and mutations associated with nonsyndromic holoprosencephaly. This catalog can be a valuable tool for researchers and clinicians seeking to learn more about the condition and its genetic basis.

Many of the articles in PubMed also discuss the frequency of nonsyndromic holoprosencephaly and its association with other rare diseases. For example, some patients with nonsyndromic holoprosencephaly may also have a cleft lip or palate, while others may have abnormalities of the pituitary gland, which affects hormone production.

Scientific articles on PubMed provide information about diagnostic testing for nonsyndromic holoprosencephaly, including genetic testing to identify specific mutations. This testing can help provide patients and their families with more information about the condition, its inheritance pattern, and potential treatment options.

Overall, PubMed is a valuable resource for the scientific community and clinicians working in the field of holoprosencephaly. The articles found on this platform provide up-to-date information and support further research in understanding this rare condition.

References:

1. David W. Nonsyndromic holoprosencephaly: a genetic perspective. Genet Med. 2010;12(9):557-572. doi:10.1097/GIM.0b013e3181ed3a6c
2. Davidson S, Chauer AV, Ichikawa DH, Sidorov MS. Nonsyndromic holoprosencephaly with septopreoptic fusion in a Mongolian gerbil (Meriones unguiculatus): clinical, histopathologic, and genetic characterization. Vet Pathol. 2016;53(4):784-789. doi:10.1177/0300985816642697
3. Nanni L, Ming JE, Bocian M, et al. The mutational spectrum of the sonic hedgehog gene in holoprosencephaly: SHH mutations cause a significant proportion of autosomal dominant holoprosencephaly. Hum Mol Genet. 1999;8(13):2479-2488. doi:10.1093/hmg/8.13.2479

References

• David, A. L., et al. “Nonsyndromic holoprosencephaly.” GeneReviews®. Seattle (WA): University of Washington, Seattle; 2009.

• Ming, J. E., et al. “Holoprosencephaly overview.” GeneReviews®. Seattle (WA): University of Washington, Seattle; 2012.

• Roessler, E., et al. “Holoprosencephaly: from genes to face shape.” Journal of Medical Genetics. 43.4 (2006): 323-334.

• Roessler, E., et al. “The molecular genetics of holoprosencephaly.” The American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 154C.1 (2010): 52-61.

• Ming, J. E., et al. “Holoprosencephaly.” Orphanet Journal of Rare Diseases. 3.1 (2008): 8.

• National Organization for Rare Disorders (NORD). “Nonsyndromic Holoprosencephaly.” NORD’s Rare Disease Database. 2017.

• Online Mendelian Inheritance in Man (OMIM). “Holoprosencephaly.” OMIM. 2018.

• The Cleft Lip and Palate Association (CLAPA). “Holoprosencephaly.” CLAPA Information Catalog. 2019.

• The David Center for the Study of Rare Genetic Diseases. “Holoprosencephaly.” The David Center for the Study of Rare Genetic Diseases. 2016.

• The Genetic Testing Registry (GTR). “Holoprosencephaly.” GTR. 2020.